Infinity Pharmaceuticals Stock Forecast - Double Exponential Smoothing

INFIDelisted Stock  USD 0.04  0.03  42.86%   
The Double Exponential Smoothing forecasted value of Infinity Pharmaceuticals on the next trading day is expected to be 0.03 with a mean absolute deviation of  0.01  and the sum of the absolute errors of 0.70. Infinity Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Infinity Pharmaceuticals stock prices and determine the direction of Infinity Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Infinity Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
  
Most investors in Infinity Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Infinity Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Infinity Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Infinity Pharmaceuticals works best with periods where there are trends or seasonality.

Infinity Pharmaceuticals Double Exponential Smoothing Price Forecast For the 24th of April

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Infinity Pharmaceuticals on the next trading day is expected to be 0.03 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0004, and the sum of the absolute errors of 0.70.
Please note that although there have been many attempts to predict Infinity Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Infinity Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Infinity Pharmaceuticals Stock Forecast Pattern

Backtest Infinity PharmaceuticalsInfinity Pharmaceuticals Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Infinity Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Infinity Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0013
MADMean absolute deviation0.0119
MAPEMean absolute percentage error0.0963
SAESum of the absolute errors0.7026
When Infinity Pharmaceuticals prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Infinity Pharmaceuticals trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Infinity Pharmaceuticals observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Infinity Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Infinity Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Infinity Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.040.04
Details
Intrinsic
Valuation
LowRealHigh
0.040.040.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Infinity Pharmaceuticals. Your research has to be compared to or analyzed against Infinity Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Infinity Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Infinity Pharmaceuticals.

View Infinity Pharmaceuticals Related Equities

 Risk & Return  Correlation

Infinity Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Infinity Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Infinity Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Infinity Pharmaceuticals stock market strength indicators, traders can identify Infinity Pharmaceuticals entry and exit signals to maximize returns.

Infinity Pharmaceuticals Risk Indicators

The analysis of Infinity Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Infinity Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting infinity stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Note that the Infinity Pharmaceuticals information on this page should be used as a complementary analysis to other Infinity Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in Infinity Stock

If you are still planning to invest in Infinity Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Infinity Pharmaceuticals' history and understand the potential risks before investing.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios